A low-dose radioisotope procedure for assessment of subcutaneous drug delivery systems used for slow intrathecal infusion of antispasmodic agents

[1]  J. Daviet,et al.  Radioisotopic control for baclofen pump catheter failure , 2001, Spinal Cord.

[2]  A. Jamous,et al.  Intrathecal baclofen–a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems , 1995, Paraplegia.

[3]  A. Verbruggen,et al.  Technetium-99m diethylene triamine pentaacetic acid for intrathecal administration: Are we playing with fire? , 1994, European Journal of Nuclear Medicine.

[4]  R. Penn,et al.  lndium‐111 DTP A Flow Study to Evaluate Surgically Implanted Drug Pump Delivery System , 1990, Clinical nuclear medicine.

[5]  J. Gybels,et al.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[6]  R. Hicks,et al.  The Radionuclide Assessment of a System for Slow Intrathecal Infusion of Drugs , 1989, Clinical nuclear medicine.

[7]  B. Wall,et al.  Radiation exposure of the UK population from medical and dental X-ray examinations. , 2001 .

[8]  A. Jamous,et al.  Complications of intrathecal baclofen delivery. , 1992, British journal of neurosurgery.

[9]  J. D. Harrison,et al.  Radiation Dose to Patients from Radiopharmaceuticals , 1988 .

[10]  R. Dom,et al.  Complications after Intrathecal Administration of Tc99m DTPA , 1982 .

[11]  Ws Snyder,et al.  MIRD Pamphlet #11: S, Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs , 1975 .

[12]  Dai-ichi Nuclear Accident,et al.  The International Commission on Radiological Protection , 1963, Nature.